1 unknown. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Collaborative Medicinal Development Pty Limited: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CuATSM Compared With Placebo for Treatment of ALS/MND Cu(II)ATSM, Placebos - Amyotrophic Lateral Sclerosis | Phase 2 / Phase 3 | Unknown | Collaborative Medicinal Development Pty Limited | 80 | 2019-09-30 | 2019-11-06 |
Amyotrophic Lateral Sclerosis (1)
copper (II) diacetyl-di(N(4)-methylthiosemicarbazone) (1)
Australia (1)
Dominic Rowe, MD (1)